Gamma counters

TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and

TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and

TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and

TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidineIn VitroTAS-114 (1-10 μM: 72 hours) increases the cytotoxicity of 5-Fluorouracil (5-FU) and

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor ( K i =31 nM, IC 50 =13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor ( K i =31 nM, IC 50 =13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor ( K i =31 nM, IC 50 =13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor ( K i =31 nM, IC 50 =13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer

Seclidemstat (SP-2577) mesylate is a potent noncompetitive and reversible KDM1A (LSD1) inhibitor ( K i =31 nM, IC 50 =13 nM). Seclidemstat mesylate promotes antitumor immunity in switch/sucrose nonfermentable (SWI/SNF) complex mutated ovarian cancer

QCA570 is a PROTAC connected by ligands for Cereblon and BET , with an IC 50 of 10 nM for BRD4 BD1 Protein.In VitroQCA570 is an extremely potent and highly efficacious BET degrader, capable of degrading BET proteins at low picomolar (pM)

QCA570 is a PROTAC connected by ligands for Cereblon and BET , with an IC 50 of 10 nM for BRD4 BD1 Protein.In VitroQCA570 is an extremely potent and highly efficacious BET degrader, capable of degrading BET proteins at low picomolar (pM)

PO-322.